Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences
Astex Pharmaceuticals, Inc. 18.09.2012 12:00 --------------------------------------------------------------------------- DUBLIN, Calif., 2012-09-18 12:00 CEST (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that members of the Astex management team will participate as presenters on oncology panels at two upcoming investor conferences. Michael V. McCullar, PhD, MBA, senior vice president, business development, will take part in a panel discussion titled, 'Targeted Oncology - Changing Cancer Therapy, Again' on Monday, September 24th at 1:00 pm ET at the Noble Financial Capital Markets Life Sciences Exposition in Stamford, Connecticut. The following week, Harren Jhoti, PhD, president and director, will participate on a panel titled 'Oncology Business Models' on Monday, October 1st at 3:15 pm CET at the Sachs Associates Biotech in Europe Investor Forum in Zurich, Switzerland. Just prior to the panel, Dr. Jhoti will deliver the Astex Pharmaceuticals corporate presentation for Forum attendees at 12 noon CET. About Astex Pharmaceuticals Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen(r) (decitabine) for Injection and receives significant royalties on global sales. For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com. The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273 CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc. Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: tim.enns@astx.com Susanna Chau Astex Pharmaceuticals, Inc. Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: susanna.chau@astx.com Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: aroemer@troutgroup.com Kari Watson MacDougall Biomedical Communications Senior Vice President Tel: +1 (781) 235-3060 E-mail: kwatson@macbiocom.com News Source: NASDAQ OMX 18.09.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Astex Pharmaceuticals, Inc. United States Phone: Fax: E-mail: Internet: ISIN: US04624B1035 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found